Löwenberg, B., Pabst, T., Maertens, J., Gradowska, P., Biemond, B. J., Spertini, O., . . . Ossenkoppele, G. J. (2021). Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: The HOVON-SAKK-132 trial. Blood Adv.
Παραπομπή Chicago StyleLöwenberg, Bob, et al. "Addition of Lenalidomide to Intensive Treatment in Younger and Middle-aged Adults With Newly Diagnosed AML: The HOVON-SAKK-132 Trial." Blood Adv 2021.
Παραπομπή MLALöwenberg, Bob, et al. "Addition of Lenalidomide to Intensive Treatment in Younger and Middle-aged Adults With Newly Diagnosed AML: The HOVON-SAKK-132 Trial." Blood Adv 2021.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.